{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:03:46Z","timestamp":1791849826541,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP571045 and APP358395"],"award-info":[{"award-number":["APP571045 and APP358395"]}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1438-3","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:03:24Z","timestamp":1562929404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhipeng","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1838-3348","authenticated-orcid":false,"given":"Brendan","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janak R.","family":"de Zoysa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Scaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"issue":"11","key":"1438_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008;73(11):1296\u2013302.","journal-title":"Kidney Int"},{"issue":"5","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","volume":"15","author":"DE Weiner","year":"2004","unstructured":"Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307\u201315.","journal-title":"J Am Soc Nephrol"},{"issue":"5 Suppl 3","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1438_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1681\/ASN.2004080656","volume":"16","author":"P Muntner","year":"2005","unstructured":"Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16(2):529\u201338.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.2215\/CJN.00810110","volume":"5","author":"H Eddington","year":"2010","unstructured":"Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(12):2251\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1438_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrneph.2013.147","volume":"9","author":"J Silver","year":"2013","unstructured":"Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013;9(11):641\u20139.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1438_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","volume":"14","author":"SM Moe","year":"2007","unstructured":"Moe SM, Drueke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007;14(1):3\u201312.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"1438_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ndt\/gfv050","volume":"30","author":"D Goldsmith","year":"2015","unstructured":"Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I, Chronic Kidney Disease-Mineral Bone Disease working g, et al. Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. Nephrol Dial Transplant. 2015;30(5):698\u2013700.","journal-title":"Nephrol Dial Transplant"},{"key":"1438_CR9","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/ki.2010.189","volume":"117","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010;117:S10\u201321.","journal-title":"Kidney Int Suppl"},{"key":"1438_CR10","first-page":"S1","volume":"113","author":"Group KDIGOCKDMBDW","year":"2009","unstructured":"Group KDIGOCKDMBDW. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"1438_CR11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","volume":"88","author":"CS Shinaberger","year":"2008","unstructured":"Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88(6):1511\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.00290109","volume":"4","author":"Y-W Chiu","year":"2009","unstructured":"Chiu Y-W, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"1438_CR13","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","volume":"363","author":"GM Chertow","year":"2010","unstructured":"Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287\u2013300.","journal-title":"N Engl J Med"},{"issue":"11","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","volume":"298","author":"BF Culleton","year":"2007","unstructured":"Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298(11):1291\u20139.","journal-title":"JAMA."},{"issue":"10","key":"1438_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ki.2011.213","volume":"80","author":"MV Rocco","year":"2011","unstructured":"Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011;80(10):1080\u201391.","journal-title":"Kidney Int"},{"issue":"2","key":"1438_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.ajkd.2014.02.016","volume":"64","author":"T Cornelis","year":"2014","unstructured":"Cornelis T, van der Sande FM, Eloot S, Cardinaels E, Bekers O, Damoiseaux J, et al. Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study. Am J Kidney Dis. 2014;64(2):247\u201356.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1438_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000330176","volume":"34","author":"B Meijers","year":"2011","unstructured":"Meijers B, Toussaint ND, Meyer T, Bammens B, Verbeke K, Vanrenterghem Y, et al. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis. Am J Nephrol. 2011;34(3):226\u201332.","journal-title":"Am J Nephrol"},{"issue":"11","key":"1438_CR18","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1093\/ndt\/gfs021","volume":"27","author":"F Tentori","year":"2012","unstructured":"Tentori F, Zhang J, Li Y, Karaboyas A, Kerr P, Saran R, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2012;27(11):4180\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1438_CR19","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1681\/ASN.2015111225","volume":"28","author":"MJ Jardine","year":"2017","unstructured":"Jardine MJ, Zuo L, Gray NA, JRd Z, Chan CT, Gallagher MP, et al. A Trial of Extending hemodialysis hours and quality of life. J Am Soc Nephrol. 2017;28(6):1898\u2013911.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1438_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/nep.12385","volume":"20","author":"MJ Jardine","year":"2015","unstructured":"Jardine MJ, Zuo LI, Gray NA, de Zoysa J, Chan CT, Gallagher MP, et al. Design and participant baseline characteristics of 'A clinical trial of IntensiVE Dialysis': the ACTIVE Dialysis study. Nephrology. 2015;20(4):257\u201365.","journal-title":"Nephrology."},{"issue":"5","key":"1438_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","volume":"93","author":"MG Vervloet","year":"2018","unstructured":"Vervloet MG, van Ballegooijen AJ. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018;93(5):1060\u201372.","journal-title":"Kidney Int"},{"issue":"2","key":"1438_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009;20(2):388\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1438_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1681\/ASN.2011070688","volume":"23","author":"JT Daugirdas","year":"2012","unstructured":"Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 2012;23(4):727\u201338.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1438_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2017.07.016","volume":"71","author":"SH Laursen","year":"2018","unstructured":"Laursen SH, Vestergaard P, Hejlesen OK. Phosphate kinetic models in hemodialysis: a systematic review. Am J Kidney Dis. 2018;71(1):75\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1438_CR25","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30(9):1542\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/nu9040372","volume":"9","author":"Giorgina Piccoli","year":"2017","unstructured":"Piccoli GB, Moio MR, Fois A, Sofronie A, Gendrot L, Cabiddu G, et al. The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach. Nutrients. 2017;9(4):372.","journal-title":"Nutrients"},{"issue":"4","key":"1438_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2014.09.012","volume":"65","author":"SC Palmer","year":"2015","unstructured":"Palmer SC, Hanson CS, Craig JC, Strippoli GF, Ruospo M, Campbell K, et al. Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies. Am J Kidney Dis. 2015;65(4):559\u201373.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1438_CR28","first-page":"658","volume":"34","author":"BS Levine","year":"2014","unstructured":"Levine BS, Rodriguez M, Felsenfeld AJ. Serum calcium and bone: effect of PTH, phosphate, vitamin D and uremia. Nefrologia. 2014;34(5):658\u201369.","journal-title":"Nefrologia."},{"key":"1438_CR29","volume-title":"2013: Dialysis of drugs","author":"GR Bailie","year":"2013","unstructured":"Bailie GR, Mason NA. 2013: Dialysis of drugs. Renal Pharmacy Consultants, LLC: Saline; 2013."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1438-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:12:47Z","timestamp":1594422767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1438-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1438-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ACTIVE Dialysis study was carried out in accordance with the principles of the Helsinki Declaration and approval was obtained from Human Research Ethics Committee of Northern Sydney Central Coast Health, NSW, Australia (HREC\/09\/HARBR\/26). Approval was also obtained from each participating site according to their local practice. Outside Australia, the study was approved by Peking University Institutional Review Board, China (IRB00001052\u201311079); Multi-region Ethics Committee, New Zealand (MEC\/09\/07\/078) and University Health Network Research Ethics Board, Canada (09\u20130820-BE). Written, informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}